St. Joseph disclosed in 2009 that federal authorities were investigating its financial relationship with a cardiology practice, prompting three top executives to resign. On top of that, one of its high-profile physicians, Dr. Mark Midei, was accused of implanting stents in hundreds of patients who didnt need the artery procedure. Midei has maintained he did nothing differently than doctors across the country.
The hospital agreed in 2010 to a $22 million settlement with the federal government, though it admitted no liability. The move resolved claims of kickbacks involving the cardiology practice and included repayment of federal funds received for questionable stent implantation.
But that didnt resolve St. Josephs longer-lasting problem: The scandal hit the hospital in its key specialty — cardiac care. Patients jumped ship. Some sued. And doctors left, too.
Despite those problems, the University of Maryland Medical System had competition for St. Joseph, with its modern facilities, affluent patients and suburban location. Then-owner Catholic Health Initiatives also received bids from Saint Agnes Hospital and LifeBridge Health.
The University of Maryland Medical System wouldnt disclose terms — other than to say what it didnt get in the sale. St. Josephs debts and liabilities, including any produced by Midei-related lawsuits, are not included.